Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1959 Nov;32(2):73–92.

Neurohumors in the Brain **

Nicholas J Giarman
PMCID: PMC2604069  PMID: 13827886

Full text

PDF
73

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABOOD L. G., OSTFELD A. M., BIEL J. A new group of psychotomimetic agents. Proc Soc Exp Biol Med. 1958 Feb;97(2):483–486. doi: 10.3181/00379727-97-23782. [DOI] [PubMed] [Google Scholar]
  2. ARUNLAKSHANA O., MONGAR J. L., SCHILD H. O. Potentiation of pharmacological effects of histamine by histaminase inhibitors. J Physiol. 1954 Jan;123(1):32–54. doi: 10.1113/jphysiol.1954.sp005032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BAKER R. V. Observations on the localization of 5-hydroxytryptamine. J Physiol. 1958 Aug 6;142(3):563–570. doi: 10.1113/jphysiol.1958.sp006036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BASEMORE A. W., ELLIOT K. A., FLOREY E. Isolation of factor I. J Neurochem. 1957;1(4):334–339. doi: 10.1111/j.1471-4159.1957.tb12090.x. [DOI] [PubMed] [Google Scholar]
  5. BLASCHKO H., WELCH A. D. Localization of adrenaline in cytoplasmic particles of the bovine adrenal medulla. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1953;219(1-2):17–22. doi: 10.1007/BF00246245. [DOI] [PubMed] [Google Scholar]
  6. BONNYCASTLE D. D., GIARMAN N. J., PAASONEN M. K. Anticonvulsant compounds and 5-hydroxytryptamine in rat brain. Br J Pharmacol Chemother. 1957 Jun;12(2):228–231. doi: 10.1111/j.1476-5381.1957.tb00125.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. BONVALLET M., DELL P., HIEBEL G. Tonus sympathique et activité électrique corticale. Electroencephalogr Clin Neurophysiol. 1954 Feb;6(1):119–144. doi: 10.1016/0013-4694(54)90011-5. [DOI] [PubMed] [Google Scholar]
  8. BRODIE B. B., SHORE P. A. A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann N Y Acad Sci. 1957 Mar 14;66(3):631–642. doi: 10.1111/j.1749-6632.1957.tb40753.x. [DOI] [PubMed] [Google Scholar]
  9. BROWN D. D., AXELROD J., TOMCHICK R. Enzymatic N-methylation of histamine. Nature. 1959 Mar 7;183(4662):680–680. doi: 10.1038/183680a0. [DOI] [PubMed] [Google Scholar]
  10. CARLSSON A., LINDQVIST M., MAGNUSSON T. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature. 1957 Nov 30;180(4596):1200–1200. doi: 10.1038/1801200a0. [DOI] [PubMed] [Google Scholar]
  11. CROSSLAND J., MITCHELL J. F. The effect on the electrical activity of the cerebellum of a substance present in cerebellar extracts. J Physiol. 1956 May 28;132(2):391–405. doi: 10.1113/jphysiol.1956.sp005533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. DALE H. H. The beginnings and the prospects of neurohumoral transmission. Pharmacol Rev. 1954 Mar;6(1):7–13. [PubMed] [Google Scholar]
  13. DELAY J., BUISSON J. F. Psychic action of isoniazid in the treatment of depressive states. J Clin Exp Psychopathol. 1958 Apr-Jun;19(2 Suppl 1):51–55. [PubMed] [Google Scholar]
  14. EADE N. R. The distribution of the catechol amines in homogenates of the bovine adrenal medulla. J Physiol. 1958 Apr 3;141(1):183–192. doi: 10.1113/jphysiol.1958.sp005966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. EIDELBERG E., FELDMAN S., MAGOUN H. W. Role of gamma-aminobutyric acid in electrocortical arousal. Neurology. 1959 Jan;9(1):15–17. doi: 10.1212/wnl.9.1.15. [DOI] [PubMed] [Google Scholar]
  16. ELLIOTT K. A. C., SWANK R. L., HENDERSON N. Effects of anesthetics and convulsants on acetylcholine content of brain. Am J Physiol. 1950 Aug 1;162(2):469–474. doi: 10.1152/ajplegacy.1950.162.2.469. [DOI] [PubMed] [Google Scholar]
  17. ELLIOTT K. A., JASPER H. H. Gammaaminobutyric acid. Physiol Rev. 1959 Apr;39(2):383–406. doi: 10.1152/physrev.1959.39.2.383. [DOI] [PubMed] [Google Scholar]
  18. FELDBERG W., HARRIS F. W., LIN R. C. Y. Observations on the presence of cholinergic and non-cholinergic neurones in the central nervous system. J Physiol. 1951 Feb;112(3-4):400–404. doi: 10.1113/jphysiol.1951.sp004537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. FELDBERG W., SHERWOOD S. L. Injections of drugs into the lateral ventricle of the cat. J Physiol. 1954 Jan;123(1):148–167. doi: 10.1113/jphysiol.1954.sp005040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. FRANCIS C. M. Cholinesterase in the retina. J Physiol. 1953 May 28;120(3):435–439. doi: 10.1113/jphysiol.1953.sp004907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. FREEDMAN D. X., GIARMAN N. J. Apomorphine test for tranquilizing drugs: effect of dibenamine. Science. 1956 Aug 10;124(3215):264–265. doi: 10.1126/science.124.3215.264. [DOI] [PubMed] [Google Scholar]
  22. FUNDERBURK W. H., CASE T. J. The effect of atropine on cortical potentials. Electroencephalogr Clin Neurophysiol. 1951 May;3(2):213–223. doi: 10.1016/0013-4694(51)90013-2. [DOI] [PubMed] [Google Scholar]
  23. Feldberg W., Vogt M. Acetylcholine synthesis in different regions of the central nervous system. J Physiol. 1948 Jun 25;107(3):372–381. doi: 10.1113/jphysiol.1948.sp004282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. GADDUM J. H., VOGT M. Some central actions of 5-hydroxytryptamine and various antagonists. Br J Pharmacol Chemother. 1956 Jun;11(2):175–179. doi: 10.1111/j.1476-5381.1956.tb01049.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. HALEY T. J. Intracerebral injection of psychotomimetic and psychotherapeutic drugs into conscious mice. Acta Pharmacol Toxicol (Copenh) 1957;13(2):107–112. doi: 10.1111/j.1600-0773.1957.tb00245.x. [DOI] [PubMed] [Google Scholar]
  26. HEBB C. O., SILVER A. Choline acetylase in the central nervous system of man and some other mammals. J Physiol. 1956 Dec 28;134(3):718–728. doi: 10.1113/jphysiol.1956.sp005678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. HEBB C. O., WHITTAKER V. P. Intracellular distributions of acetylcholine and choline acetylase. J Physiol. 1958 Jun 18;142(1):187–196. doi: 10.1113/jphysiol.1958.sp006008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. HELLAUER H. F., UMRATH K. Ueber die Aktionssubstanz der sensiblen Nerven. Pflugers Arch Gesamte Physiol Menschen Tiere. 1948;249(6-7):619–630. [PubMed] [Google Scholar]
  29. HOLZBAUER M., VOGT M. Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat. J Neurochem. 1956 May;1(1):8–11. doi: 10.1111/j.1471-4159.1956.tb12048.x. [DOI] [PubMed] [Google Scholar]
  30. IWAMA K., JASPER H. H. The action of gamma aminobutyric acid upon cortical electrical activity in the cat. J Physiol. 1957 Oct 30;138(3):365–380. doi: 10.1113/jphysiol.1957.sp005856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. KILLAM K. F., BAIN J. A. Convulsant hydrazides. I. In vitro and in vivo inhibition of vitamin B6 enzymes by convulsant hydrazides. J Pharmacol Exp Ther. 1957 Feb;119(2):255–262. [PubMed] [Google Scholar]
  32. KOPERA H., LAZARINI W. Zur Frage der zentralen Ubertragung afferenter Impulse. IV. Die Verteilung der Substanz P im Zentralnervensystem. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1953;219(3):214–222. [PubMed] [Google Scholar]
  33. KURIAKI K., YAKUSHIJI T., NORO T., SHIMIZU T., SAJI S. gamma-Aminobutyrylcholine. Nature. 1958 May 10;181(4619):1336–1337. doi: 10.1038/1811336a0. [DOI] [PubMed] [Google Scholar]
  34. LECHNER H., LEMBECK F. Einfluss der Substanz P auf die elektrische Aktivität des Gehirns. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1958;234(5):419–425. [PubMed] [Google Scholar]
  35. Macintosh F. C. The distribution of acetylcholine in the peripheral and the central nervous system. J Physiol. 1941 Jun 30;99(4):436–442. doi: 10.1113/jphysiol.1941.sp003913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. McKHANN G. M., TOWER D. B. gamma-Aminobutyric acid: a substrate for oxidative metabolism of cerebral cortex. Am J Physiol. 1959 Jan;196(1):36–38. doi: 10.1152/ajplegacy.1958.196.1.36. [DOI] [PubMed] [Google Scholar]
  37. PAASONEN M. K., GIARMAN N. J. Brain levels of 5-hydroxytryptamine after various agents. Arch Int Pharmacodyn Ther. 1958 Mar 1;114(2):189–200. [PubMed] [Google Scholar]
  38. PAASONEN M. K., MACLEAN P. D., GIARMAN N. J. 5-Hydroxytryptamine (serotonin, enteramine) content of structures of the limbic system. J Neurochem. 1957;1(4):326–333. doi: 10.1111/j.1471-4159.1957.tb12089.x. [DOI] [PubMed] [Google Scholar]
  39. PAASONEN M. K., VOGT M. The effect of drugs on the amounts of substance P and 5-hydroxytryptamine in mammalian brain. J Physiol. 1956 Mar 28;131(3):617–626. doi: 10.1113/jphysiol.1956.sp005486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. PATON W. D. Central and synaptic transmission in the nervous system; pharmacological aspects. Annu Rev Physiol. 1958;20:431–470. doi: 10.1146/annurev.ph.20.030158.002243. [DOI] [PubMed] [Google Scholar]
  41. PURPURA D. P., GIRADO M., GRUNDFEST H. Selective blockade of excitatory synapses in the cat brain by gamma-aminobutyric acid. Science. 1957 Jun 14;125(3259):1200–1202. doi: 10.1126/science.125.3259.1200-a. [DOI] [PubMed] [Google Scholar]
  42. RICHTER D., CROSSLAND J. Variation in acetylcholine content of the brain with physiological state. Am J Physiol. 1949 Nov;159(2):247–255. doi: 10.1152/ajplegacy.1949.159.2.247. [DOI] [PubMed] [Google Scholar]
  43. ROBERTS E., BREGOFF H. M. Transamination of gamma-aminobutyric acid and beta-alanine in brain and liver. J Biol Chem. 1953 Mar;201(1):393–398. [PubMed] [Google Scholar]
  44. ROBERTS E., FRANKEL S. gamma-Aminobutyric acid in brain: its formation from glutamic acid. J Biol Chem. 1950 Nov;187(1):55–63. [PubMed] [Google Scholar]
  45. ROBERTS E., ROTHSTEIN M., BAXTER C. F. Some metabolic studies of gamma-aminobutyric acid. Proc Soc Exp Biol Med. 1958 Apr;97(4):796–802. doi: 10.3181/00379727-97-23883. [DOI] [PubMed] [Google Scholar]
  46. ROTHSCHILD Z., SCHAYER R. W. Synthesis and metabolism of a histamine metabolite, 1-methyl-4 (beta-aminoethyl)-imidazole. Biochim Biophys Acta. 1958 Oct;30(1):23–27. doi: 10.1016/0006-3002(58)90236-1. [DOI] [PubMed] [Google Scholar]
  47. STEWART W. C. Accumulation of acetylcholine in brain and blood of animals poisoned with cholinesterase inhibitors. Br J Pharmacol Chemother. 1952 Jun;7(2):270–276. doi: 10.1111/j.1476-5381.1952.tb01322.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. STONE W. E. The role of acetylcholine in brain metabolism and function. Am J Phys Med. 1957 Aug;36(4):222–255. [PubMed] [Google Scholar]
  49. TOWER D. B., ELLIOTT K. A. C. Activity of acetylcholine system in human epileptogenic focus. J Appl Physiol. 1952 Feb;4(8):669–676. doi: 10.1152/jappl.1952.4.8.669. [DOI] [PubMed] [Google Scholar]
  50. TRENDELENBURG U. The potentiation of ganglionic transmission by histamine and pilocarpine. J Physiol. 1955 Aug 29;129(2):337–351. doi: 10.1113/jphysiol.1955.sp005358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. VOGT M. The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. J Physiol. 1954 Mar 29;123(3):451–481. doi: 10.1113/jphysiol.1954.sp005064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. VON EULER U. S., PERNOW B. Neurotropic effects of substance P. Acta Physiol Scand. 1956 May 18;36(3):265–275. doi: 10.1111/j.1748-1716.1956.tb01324.x. [DOI] [PubMed] [Google Scholar]
  53. Woolley D. W., Shaw E. A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS. Proc Natl Acad Sci U S A. 1954 Apr;40(4):228–231. doi: 10.1073/pnas.40.4.228. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES